Clinical trial
The Effects of Nicotine on Cognition in Schizophrenia
NCT00383747 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00383747 |
|---|---|
| Title | The Effects of Nicotine on Cognition in Schizophrenia |
| Official title | A Double Blind Placebo Controlled Trial of the Effects of Transdermal Nicotine on Cognitive Function in Non-Smokers With and Without Schizophrenia |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Stanley Medical Research Institute North Suffolk Mental Health Association |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | transdermal nicotine patch, Transdermal Nicotine Patch |
| Enrollment | 60 |
| Start date | Apr 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Oct 3, 2006 |
| Last update posted | Apr 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: